Skip to main content
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1978 Feb;37(1):98–100. doi: 10.1136/ard.37.1.98

Cholestatic jaundice caused by D-penicillamine.

D Barzilai, G Dickstein, R Enat, H Bassan, C Lichtig, B Gellei
PMCID: PMC1000201  PMID: 629612

Abstract

D-penicillamine is not generally considered to cause hepatic damage. Cholestatic jaundice developed in a patient with rheumatoid arthritis 4 weeks after penicillamine was added to his regimen, and he died in acute renal failure. The probability that penicillamine caused the cholestasis is discussed.

Full text

PDF
98

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bar-Shany S., Naggan L., Wolpiansky N. Hepatitis-associated antigen in 10,000 Israel blood donors. Isr J Med Sci. 1972 Jan;8(1):1–6. [PubMed] [Google Scholar]
  2. Bucknall R. C., Dixon A St J., Glick E. N., Woodland J., Zutshi D. W. Myasthenia gravis associated with penicillamine treatment for rheumatoid arthritis. Br Med J. 1975 Mar 15;1(5958):600–602. doi: 10.1136/bmj.1.5958.600. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fulop M., Katz S., Lawrence C. Extreme hyperbilirubinemia. Arch Intern Med. 1971 Feb;127(2):254–258. [PubMed] [Google Scholar]
  4. Garber E., Craig R. M., Bahu R. M. Letter: Aspirin hepatotoxicity. Ann Intern Med. 1975 Apr;82(4):592–593. doi: 10.7326/0003-4819-82-4-592_2. [DOI] [PubMed] [Google Scholar]
  5. Iancu T. Serum transaminases and salicylate therapy. Br Med J. 1972 Apr 15;2(5806):167–167. doi: 10.1136/bmj.2.5806.167. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Oliver I., Liberman U. A., DeVries A. Lupus-like syndrome induced by penicillamine in cystinuria. JAMA. 1972 Apr 24;220(4):588–588. doi: 10.1001/jama.1972.03200040100036. [DOI] [PubMed] [Google Scholar]
  7. Rau R., Weber S., Böni A. Allergisch-toxische Leberschädigung durch D-Penizillamin. Schweiz Med Wochenschr. 1972 Aug 26;102(34):1226–1228. [PubMed] [Google Scholar]
  8. Rich R. R., Johnson J. S. Salicylate hepatotoxicity in patients with juvenile rheumatoid arthritis. Arthritis Rheum. 1973 Jan-Feb;16(1):1–9. doi: 10.1002/art.1780160102. [DOI] [PubMed] [Google Scholar]
  9. Russell A. S., Sturge R. A., Smith M. A. Serum transaminases during salicylate therapy. Br Med J. 1971 May 22;2(5759):428–429. doi: 10.1136/bmj.2.5759.428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Seaman W. E., Ishak K. G., Plotz P. H. Aspirin-induced hepatotoxicity in patients with systemic lupus erythematosus. Ann Intern Med. 1974 Jan;80(1):1–8. doi: 10.7326/0003-4819-80-1-1. [DOI] [PubMed] [Google Scholar]
  11. Sternlieb I., Bennett B., Scheinberg I. H. D-penicillamine induced Goodpasture's syndrome in Wilson's disease. Ann Intern Med. 1975 May;82(5):673–676. doi: 10.7326/0003-4819-82-5-673. [DOI] [PubMed] [Google Scholar]
  12. Wolfe J. D., Metzger A. L., Goldstein R. C. Aspirin hepatitis. Ann Intern Med. 1974 Jan;80(1):74–76. doi: 10.7326/0003-4819-80-1-74. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES